Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Caffeine and Sleep Restriction in Teenagers (CaReTeens)
NCT05790161Unknown
- Sponsor
- Universitäre Psychiatrische Kliniken Basel
- Start
- Mar 2023
- Primary completion
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of caffeine in insufficient sleep syndrome (ISS), sponsored by Universitäre Psychiatrische Kliniken Basel. Primary endpoints: Nighttime Sleep Slow Wave Activity at 2 weeks and BOLD activity during reward processing at 2 weeks. Status: unknown.
02
Drugs
caffeine
03
Conditions
insufficient sleep syndrome (ISS)
Beyond the preview
Go deeper on NCT05790161.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05790161.